Area of research
Biomedical Engineering · Molecular Biology
Research interest
Research focused on Cancer research and Prodrug, with related work in Immunotherapy, Protein degradation, Tumor microenvironment. Notable publications include 'Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy', 'From structural design to delivery: mRNA therapeutics for cancer immunotherapy', and 'Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer'.
A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy
Tumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy
A Self-Immobilizing Photosensitizer with Long-Term Retention for Hypoxia Imaging and Enhanced Photodynamic Therapy
From structural design to delivery: mRNA therapeutics for cancer immunotherapy
Self‐Adaptive Nanoregulator to Mitigate Dynamic Immune Evasion of Pancreatic Cancer
Photochemically controlled activation of STING by CAIX-targeting photocaged agonists to suppress tumor cell growth
Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy
In Situ Reconstruction NiO Octahedral Active Sites for Promoting Electrocatalytic Oxygen Evolution of Nickel Phosphate
Engineering Chameleon Prodrug Nanovesicles to Increase Antigen Presentation and Inhibit PD‐L1 Expression for Circumventing Immune Resistance of Cancer
Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer
Stimuli‐activatable nanomedicines for chemodynamic therapy of cancer
Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer
Polydopamine‐Functionalized Graphene Oxide Loaded with Gold Nanostars and Doxorubicin for Combined Photothermal and Chemotherapy of Metastatic Breast Cancer
Reversal of Lung Cancer Multidrug Resistance by pH-Responsive Micelleplexes Mediating Co-Delivery of siRNA and Paclitaxel